NAGLU mutations underlying Sanfilippo syndrome type B

被引:51
作者
Schmidtchen, A
Greenberg, D
Zhao, HG
Li, HH
Huang, Y
Tieu, P
Zhao, HZ
Cheng, SS
Zhao, ZY
Whitley, CB
Di Natale, P
Neufeld, EF
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA
[3] Univ Minnesota, Sch Med, Inst Human Genet, Minneapolis, MN 55455 USA
[4] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[5] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Naples, Italy
关键词
D O I
10.1086/301685
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Sanfilippo syndrome type B (mucopolysaccharidosis III B) is a rare autosomal recessive disease caused by deficiency of alpha-N-acetylglucosaminidase, one of the enzymes required for the lysosomal degradation of heparan sulfate. The gene for this enzyme, NAGLU, recently was isolated, and several mutations were characterized. We have identified, in amplified exons from nine fibroblast cell lines derived from Sanfilippo syndrome type B patients, 10 additional mutations: Y92H, P115S, Y140C, E153K, R203X, 650insC, 901delAA, P358L, AG64V, and L682R. Four of these mutations were found in homozygosity, and only two were seen in more than one cell line. Thus, Sanfilippo syndrome type B shows extensive molecular heterogeneity. Stable transfection of Chinese hamster ovary cells, by cDNA mutagenized to correspond to the NAGLU missense mutations, did not yield active enzyme, demonstrating the deleterious nature of the mutations. Nine of the 10 amino acid substitutions identified to date are clustered near the amino or the carboxyl end of alpha-N-acetylglucosaminidase, suggesting a role for these regions in the transport or function of the enzyme.
引用
收藏
页码:64 / 69
页数:6
相关论文
共 17 条
[1]  
Aronovich E. L., 1996, American Journal of Human Genetics, V59, pA246
[2]   4-METHYLUMBELLIFERYL 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSIDE, A FLUOROGENIC SUBSTRATE FOR N-ACETYL-ALPHA-D-GLUCOSAMINIDASE [J].
CHOW, P ;
WEISSMANN, B .
CARBOHYDRATE RESEARCH, 1981, 96 (01) :87-93
[3]   MANAGEMENT OF MUCOPOLYSACCHARIDOSIS TYPE-III [J].
CLEARY, MA ;
WRAITH, JE .
ARCHIVES OF DISEASE IN CHILDHOOD, 1993, 69 (03) :403-406
[4]   22 GENES FROM CHROMOSOME-17Q21 - CLONING, SEQUENCING, AND CHARACTERIZATION OF MUTATIONS IN BREAST-CANCER FAMILIES AND TUMORS [J].
FRIEDMAN, LS ;
OSTERMEYER, EA ;
LYNCH, ED ;
WELCSH, P ;
SZABO, CI ;
MEZA, JE ;
ANDERSON, LA ;
DOWD, P ;
LEE, MK ;
ROWELL, SE ;
ELLISON, J ;
BOYD, J ;
KING, MC .
GENOMICS, 1995, 25 (01) :256-263
[5]   OVEREXPRESSION OF THE HUMAN LYSOSOMAL-ENZYME ALPHA-L-IDURONIDASE IN CHINESE-HAMSTER OVARY CELLS [J].
KAKKIS, ED ;
MATYNIA, A ;
JONAS, AJ ;
NEUFELD, EF .
PROTEIN EXPRESSION AND PURIFICATION, 1994, 5 (03) :225-232
[6]   A GENERAL-METHOD FOR RAPID SITE-DIRECTED MUTAGENESIS USING THE POLYMERASE CHAIN-REACTION [J].
LANDT, O ;
GRUNERT, HP ;
HAHN, U .
GENE, 1990, 96 (01) :125-128
[7]  
MURATA R, 1989, AM J NEURORADIOL, V10, P1165
[8]  
Nenfeld EF., 1995, The Metabolic and Molecular Basis of Inherited Disease, V7, P2465
[9]   RAPID AND SENSITIVE DETECTION OF POINT MUTATIONS AND DNA POLYMORPHISMS USING THE POLYMERASE CHAIN-REACTION [J].
ORITA, M ;
SUZUKI, Y ;
SEKIYA, T ;
HAYASHI, K .
GENOMICS, 1989, 5 (04) :874-879
[10]  
PAW BH, 1991, AM J HUM GENET, V48, P1139